Welcome, Guest. Please login or register.
October 21, 2017, 12:22:41 AM

Login with username, password and session length

  • Total Members: 31667
  • Latest: Kaz86
  • Total Posts: 721005
  • Total Topics: 58484
  • Online Today: 238
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 AM)
Users Online
Users: 2
Guests: 235
Total: 237


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: HIVís 'Pathogenic Landscape' Research Identifies New Drug Targets  (Read 1533 times)

0 Members and 1 Guest are viewing this topic.

Offline tednlou2

  • Member
  • Posts: 5,731
HIVís 'Pathogenic Landscape' Research Identifies New Drug Targets

A University of California at San Francisco (UCSF)Ėled team of researchers believes it has succeeded in mapping every apparent physical interaction HIV makes with components of the immune system cells it infects, work the researchers say should ultimately reveal new therapeutic and curative drugs. The encouraging findings are reported in two papers published in the December 21 issue of Nature.
As highlighted in one paper, authored by Nevan Krogan, PhD, of UCSF and his colleagues, HIV has a small genome, and therefore its replication relies heavily on the cellular machinery of its host, notably human CD4 cells. As the development of new therapies and curative approaches ultimately requires researchers to fully understand these interactionsóand uncover ways to both prevent these interactions from occurring and disentangle them once the connections have occurredóit is necessary to first identify which cellular components come into physical contact with HIVís proteins.

In its paper titled ďGlobal Landscape of HIV-Human Protein Complexes,Ē Kroganís group highlights the methods it undertook to discover 497 connections between HIV and 435 individual human proteins. Only a handful of these connections, the authors note, have been recognized thus far by scientists.

Disrupting these connections may interfere with HIVís lifecycle, the authors note, and the existence of so many new connections suggests there may be several novel ways to target the virus.

In the second Nature paper, Krogan and his colleagues investigated one such connection in detail. They discovered that an HIV protein called Vif makes a physical connection with a human protein called CBF-β, hijacking its function. When this occurs, Vif is able to recruit CBF-β and, when working in tandem with other proteins in the body, can dismantle an enzyme called APOBEC3G, a natural defense against viral replication in the human body.

Another example, highlighted in the first paper, includes the Pol interaction network. The gene Pol is the source of several important viral proteins that are essential to HIVís infectious lifecycle. Four major antiretroviral drug classes block Polís three major proteins: reverse transcriptase (RT), protease and integrase.  Kroganís group documented dozens of interactions between RT, protease and integrase and human proteins, most of which were not previously known to exist.

Multiple virus-host interactions involving other HIV proteins were also highlighted. According to Kroganís group, there are numerous interactions between human proteins and proteins produced by the Gag gene, which help form the internal architecture of virus particles assembled inside infected cells. The same goes for HIVís Env gene, which produces the large envelope proteins Gp160, Gp120 and Gp41 that protrude from HIVís membranes and facilitate its entry into human cellsóthese proteins interact with dozens of human proteins, only a handful of which were previously known.



Terms of Membership for these forums

© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.